Mean dose to the tongue mucosa did not improve predictions of taste impairment during and after radiation therapy compared ...

Cancers occurring in the mouth, nose, and throat are on the rise in the U.S., especially in younger people. About 60,000 new ...

Designation applies to the treatment of adult patients with recurrent or metastatic head and neck squamous cell carcinoma ...

Cancers occurring in the mouth, nose, and throat are on the rise in the U.S., especially in younger people. About 60,000 new ...

Ficerafusp alfa enters phase 2/3 trial for recurrent/metastatic head and neck cancer, evaluating its combination with ...

Oropharyngeal cancer, or throat cancer, is a type of head and neck cancer that can be divided into two subgroups: ...

Head and neck cancer is diagnosed in at least 700,000 patients each year. A team of 27 doctors has found a comforting means ...

Merck & Co. has won U.S. Food and Drug Administration priority review for its application seeking expanded use of its blockbuster cancer drug Keytruda in certain patients with head and neck cancer.

HPV16+ Cancers Market Insights, Epidemiology, and Market Forecast – 2034 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, ...

University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center scientists have discovered a novel subset of ...

Recent studies show how dietary choices may affect a person's risk of cancer, particularly colorectal cancer, and cancer of the head and neck.